CTC
EXAS

Central Trust Company’s Exact Sciences EXAS Stock Holding History

Central Trust Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$69 – 1450
2024
Q3 		$69 Sell
1
-99
-99% -$5.59K ﹤0.01% 1424
2024
Q2 		$4.22K Buy
100
+50
+100% +$2.75K ﹤0.01% 1192
2024
Q1 		$3.45K Hold
50
– – ﹤0.01% 1214
2023
Q4 		$3.7K Hold
50
– – ﹤0.01% 1205
2023
Q3 		$3.41K Hold
50
– – ﹤0.01% 1191
2023
Q2 		$4.7K Buy
+50
New +$3.9K ﹤0.01% 1098
2022
Q4 		– Sell
-39
Closed -$1K – 1268
2022
Q3 		$1K Hold
39
– – ﹤0.01% 1250
2022
Q2 		$2K Hold
39
– – ﹤0.01% 1212
2022
Q1 		$3K Hold
39
– – ﹤0.01% 1204
2021
Q4 		$3K Hold
39
– – ﹤0.01% 1172
2021
Q3 		$4K Hold
39
– – ﹤0.01% 1131
2021
Q2 		$5K Hold
39
– – ﹤0.01% 1083
2021
Q1 		$5K Hold
39
– – ﹤0.01% 1007
2020
Q4 		$5K Hold
39
– – ﹤0.01% 963
2020
Q3 		$4K Hold
39
– – ﹤0.01% 952
2020
Q2 		$3K Hold
39
– – ﹤0.01% 973
2020
Q1 		$2K Hold
39
– – ﹤0.01% 1065
2019
Q4 		$4K Sell
39
-11
-22% -$967 ﹤0.01% 1073
2019
Q3 		$5K Sell
50
-100
-67% -$11.4K ﹤0.01% 1037
2019
Q2 		$18K Buy
150
+100
+200% +$10.1K ﹤0.01% 813
2019
Q1 		$4K Hold
50
– – ﹤0.01% 1019
2018
Q4 		$3K Buy
+50
New +$3.43K ﹤0.01% 1079
2018
Q3 		– Sell
-150
Closed -$9K – 1250
2018
Q2 		$9K Buy
150
+50
+50% +$2.69K ﹤0.01% 1011
2018
Q1 		$4K Buy
+100
New +$4.88K ﹤0.01% 1148
2017
Q3 		– Sell
-250
Closed -$9K – 1274
2017
Q2 		$9K Buy
250
+150
+150% +$4.63K ﹤0.01% 960
2017
Q1 		$2K Buy
+100
New +$1.98K ﹤0.01% 1100

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Central Trust Company's EXAS Position: Q4 2024 in Review

Central Trust Company sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 1 share — an estimated $69 sold.

Central Trust Company first reported a position in EXAS in Q1 2017 and held it in 26 quarters. The position peaked at $18K in Q2 2019. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Central Trust Company reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Central Trust Company sold 1 Exact Sciences share in Q4 2024, an estimated $69.
  • Central Trust Company first reported a position in Exact Sciences in Q1 2017 and held it in 26 quarters.
  • Central Trust Company's Exact Sciences position peaked at $18K in Q2 2019.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Central Trust Company's 13F filing for Q4 2024, filed 24 Jan 2025.